| Recurrence (n = 27) | Non-recurrence (n = 57) | p-value |
---|---|---|---|
Sex | Â | Â | 0.64 |
 Male (%) | 16 (59.3) | 30 (52.6) |  |
 Female (%) | 11 (40.7) | 27 (47.4) |  |
Age (year) | Â | Â | 0.95 |
 Median (range) | 65 (38–79) | 67 (40–80) |  |
Pathological histotype | Â | Â | 0.48 |
 Non poor (%) | 18 (66.7) | 33 (57.9) |  |
 Poor (%) | 9 (33.3) | 24 (42.1) |  |
Location | Â | Â | 0.62 |
 Right (%) | 7 (25.9) | 19 (33.3) |  |
 Left (%) | 20 (74.1) | 38 (66.7) |  |
Depth | Â | Â | 0.23 |
  < T4 (%) | 20 (74.1) | 49 (86.0) |  |
  ≥ T4 (%) | 7 (25.9) | 8 (14.0) |  |
Stage | Â | Â | 0.14 |
 II (%) | 5 (18.5) | 4 (7.0) |  |
 III (%) | 22 (81.5) | 53 (93.0) |  |
Smoking status | Â | Â | 0.64 |
 Brinkman index |  |  |  |
  ≥ 400 (%) | 12 (44.4) | 22 (64.7) |  |
  < 400 (%) | 15 (55.6) | 35 (70.0) |  |
Alcoholic drinking | Â | Â | 0.66 |
 Habitual drinkera (%) | 1 (3.7) | 5 (8.8) |  |
 Non-habitual drinker (%) | 26 (96.3) | 52 (91.2) |  |
Adjuvant regimen | Â | Â | 0.72 |
 Oxaliplatin combinationb (%) | 8 (38.1) | 13 (61.9) |  |
 Cape (%) | 7 (24.1) | 22 (75.9) |  |
 S-1 (%) | 7 (35.0) | 13 (65.0) |  |
 UFT + LV (%) | 5 (35.7) | 9 (64.3) |  |